Immunosuppressant Drug Testing Controls and Calibrators
Immunosuppressant Drug Testing Controls and Calibrators
Thermo Scientific™ QMS™ Therapeutic Drug Monitoring (TDM) Calibrators
Accurately measure therapeutic drug levels in serum and plasma with Thermo Scientific™ QMS™ TDM Calibrators, offered in Levels A to F.
Thermo Scientific™ QMS™ Therapeutic Drug Monitoring (TDM) Controls
Ensure accurate results when testing with the newest TDM reagents with Thermo Scientific™ QMS™ TDM Controls, offered in three levels.
Thermo Scientific™ CEDIA™ Mycophenolic Acid Immunoassays, Calibrators and Controls
Complete your ISD panel with the Thermo Scientific™ CEDIA™ Mycophenolic Acid Immunoassay.
Thermo Scientific™ QMS™ Tacrolimus Immunoassays and Calibrators
Achieve excellent low-end precision and sensitivity with the Thermo Scientific™ QMS™ Tacrolimus Immunoassay.
Thermo Scientific™ CEDIA™ Therapeutic Drug Monitoring (TDM) Calibrators
Save time while maintaining accuracy with economical Thermo Scientific™ CEDIA™ Therapeutic Drug Monitoring (TDM) Calibrators, optimized for use with CEDIA TDM Assays.
Thermo Scientific™ QMS™ Everolimus Immunoassays, Calibrators and Controls
Obtain results you can count on for immunosuppressant drug monitoring with the Thermo Scientific™ QMS™ Everolimus Immunoassay.
AdipoGen Amikacin disulfate salt
Chemical. CAS 39831-55-5. Formula C22H43N5O13 . 2H2SO4. MW 781.76. Amikacin is a broad-spectrum aminoglycoside antibiotic and a semisynthetic analog of kanamycin. It irreversibly binds to 16S rRNA and the RNA-binding S12 protein of the 30S subunit and 50S subunit of prokaryotic ribosome and inhibits protein synthesis. It works in a concentration-dependent manner, and has better action in an alkaline environment. Amikacin disulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains, due to its resistance to inactivating enzymes. Amikacin disulfate also inhibits the infections caused by susceptible Nocardia and nontuberculous mycobacteria. Amikacin can be used to treat non-tubercular mycobacterial infections and tuberculosis when first-line drugs fail to control the infection.
Cayman Chemical MycophenolIc AcId 50mg
An NSAID and a prodrug form of 6-methoxy naphthalene acetic acid reduces carrageenan-induced edema in rats from 5-45 mg/kg as well as UV-induced erythema in guinea pigs (ED50 11 mg/kg) reduces phenyl-p-quinone-induced writhing in mice (ED50 152 mg/kg) reduces endotoxin-induced pyresis in rabbits at 50 100 and 200 mg/kg
Cayman Chemical EverolImus-d4 500ug
An inhibitor of PDE1 that has diverse cerebral and neurological effects in vivo also directly inhibits IKKB (IC50 17 UM in a cell-free system) and blocks TNF-a- and LPS-mediated activation of NF-KB in cells and in vivo
Cayman Chemical MycophenolIc AcId DGlucuro 5mg
A metabolite of tamoxifen that is produced by the action of flavin-containing monooxygenases
Cayman Chemical MycophenolIc AcId 100mg
Source Recombinant human ubiquitin expressed in E coli Amino acids 1-76 MW 8 5 kDa
Cayman Chemical Mycophenolc ACD mthyl Ste 50mg
An H /K -ATPase inhibitor (Ki 46 nM) inhibits histamine- or dibutyryrl-cAMP-induced acid production in isolated rabbit gastric glands (IC50s 0.28 and 0.26 UM respectively)
Cayman Chemical 13C17-MycophenolIc AcId 1.2mL
CB1R Reporter Cells are prepared using INDIGOs proprietary CryoMite process This cryo-preservation method yields high cell viability post-thaw and provides the convenience of immediately dispensing healthy division-competent reporter cells into assay plates There is no need for intermediate spin-and-wash steps viability determinations or cell titer adjustments [INDIGO Catalog Nos IB19001-32 IB19001 IB19002]
AdipoGen Everolimus
Chemical. CAS 159351-69-6. Formula C53H83NO14. MW 958.2. Isolated from Streptomyces hygroscopicus. Macrolide antibiotic, inhibiting bacterial protein synthesis. Potent immunosuppressant. Binds with high affinity to the FK506 binding protein-12 FKBP-12 to generate an immunosuppressive complex that inhibits the activation of the mammalian target of rapamycin mTOR. More selective for the mTORC1 protein complex, with little impact on the mTORC2 complex, compared to Rapamycin. Anticancer agent. Inhibition of mTOR reduces the activity of effectors downstream, which leads to a blockage in the progression of cells from G1 into S phase, and subsequently inducing cell growth arrest, apoptosis and autophagy, resulting in reduction of cell proliferation, angiogenesis and glucose uptake. Inhibits tumor proliferation in vitro and in vivo.
Abcam Everolimus, mTOR inhibitor.
This product is for research use only and not for diagnostic or therapeutic procedures. Customer is granted a limited, non-exclusive license for internal research and shall not attempt to reverse engineer.
Everolimus, mTOR inhibitor.